Analysis of the disease burden of pancreatitis in China from 1990 to 2019_Chinese Journal of Evidence-Based Medicine

Authors：

JIANG Mengke ^1,2 , LU Zongqing ^1,2 , ZHOU Wuming ^1,2 , LIU Wanjun ^1,2 ,  YANG Min ^1,2

1. The Laboratory of Cardiopulmonary Resuscitation and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P. R. China;
2. The Second Department of Intensive Care Unit, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P. R. China;

Corresponding?author：

YANG Min, Email: yangmin@ahmu.edu.cn

Keywords：

Pancreatitis; Incidence; Mortality; Burden of disease

DOI：

10.7507/1672-2531.202203063

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective This study aimed to analyze the disease burden of pancreatitis in China from 1990 to 2019 and to provide references for the prevention and treatment of pancreatitis. Methods The data were obtained from the Global Burden of Disease Study 2019 (GBD 2019). The incidence, mortality, disability-adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs) and their corresponding age-standardized rate, and annual average percentage change (AAPC) were selected as the main indicators to compare the burden of pancreatitis in China, the United States and globally from 1990 to 2019. Results In 2019, the age-standardized incidence, mortality, DALY, YLL, and YLD rates in China were 26.76/100 000, 0.59/100 000, 16.09/100 000, 14.61/100 000, and 1.48/100 000, respectively, and decreased by 8.94%, 45.33%, 49.12%, 50.98%, and 18.49%, respectively, compared with those in 1990. The burden of pancreatitis in China gradually increased with age, but was lower than that in the United States and globally. The DALY due to alcohol continually increased in China, the United States, and globally. Conclusion From 1990 to 2019, the burden of pancreatitis in China shows a decreasing trend and is lower than that in the United States and globally. However, the disease burden caused by alcohol and aging is increasing; therefore, effective measurements to alleviate the burden of pancreatitis in China are needed.

Citation： JIANG Mengke, LU Zongqing, ZHOU Wuming, LIU Wanjun, YANG Min. Analysis of the disease burden of pancreatitis in China from 1990 to 2019. Chinese Journal of Evidence-Based Medicine, 2022, 22(8): 869-875. doi: 10.7507/1672-2531.202203063 Copy

1.	中華醫學會外科學分會胰腺外科學組. 中國急性胰腺炎診治指南(2021). 中華消化外科雜志, 2021, 20(7): 730-739.
2.	Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology, 2016, 16(2): 218-224.
3.	Sankaran SJ, Xiao AY, Wu LM, et al. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology, 2015, 149(6): 1490-1500.
4.	Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology, 2013, 144(6): 1252-1261.
5.	Pokras S, Ray M, Zheng S, et al. The short- and long-term burden of acute pancreatitis in the United States: a retrospective cohort study. Pancreas, 2021, 50(3): 330-340.
6.	GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1204-1222.
7.	GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1223-1249.
8.	GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1789-1858.
9.	屈彥, 王天一, 楊津, 等. GBD數據庫的數據提取方法與流程. 中國循證心血管醫學雜志, 2019, 11(9): 1043-1046.
10.	孟令昊, 胥秋艷, 李科, 等. 1990~2019年中國女性宮頸癌疾病負擔變化的分析. 中國循證醫學雜志, 2021, 21(6): 648-653.
11.	王娜, 劉潔, 李曉東, 等. 中國1990~2019年結直腸癌疾病負擔分析. 中國循證醫學雜志, 2021, 21(5): 520-524.
12.	Naghavi M, Makela S, Foreman K, et al. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr, 2010, 8: 9.
13.	宇傳華, 白建軍. 社會人口指數(SDI)的概念及其應用. 公共衛生與預防醫學, 2020, 31(1): 5-10.
14.	李輝章, 杜靈彬. Joinpoint回歸模型在腫瘤流行病學時間趨勢分析中的應用. 中華預防醫學雜志, 2020, 54(8): 908-912.
15.	曾四清. Joinpoint回歸模型及其在傳染病流行趨勢分析中的應用. 中國衛生統計, 2019, 36(5): 787-791.
16.	Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet. 2020, 396(10252): 726-734.
17.	Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas, 2006, 33(4): 323-330.
18.	Zheng Y, Zhou Z, Li H, et al. A multicenter study on etiology of acute pancreatitis in Beijing during 5 years. Pancreas, 2015, 44(3): 409-414.
19.	寧吉喆. 第七次全國人口普查主要數據情況. 中國統計, 2021, (5): 4-5.
20.	Roberts SE, Akbari A, Thorne K, et al. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther, 2013, 38(5): 539-548.
21.	Ouyang G, Pan G, Liu Q, et al. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. BMC Med, 2020, 18(1): 388.
22.	向斌, 張國培, 崔華永, 等. 大黃鼻飼對重癥胰腺炎腹腔感染的療效及對血管內皮糖萼的影響. 中國老年學雜志, 2021, 41(22): 4943-4946.
23.	馬玉景, 郎曉猛, 康欣, 等. 不同中藥注射液聯合常規治療用于重癥急性胰腺炎療效與安全性的網狀Meta分析. 中草藥, 2021, 52(24): 7583-7595.
24.	方婷, 莊一渝, 趙明明, 等. 重癥急性胰腺炎病人應用芒硝外敷護理效果的系統評價. 護理研究, 2018, 32(1): 49-54.
25.	黃野, 李紅昌, 孫文杰, 等. 大承氣湯治療重癥急性胰腺炎多中心隨機對照研究. 中國中西醫結合雜志, 2019, 39(8): 949-953.
26.	Yang C, Wang T, Chen J, et al. Traditional Chinese medicine formulas alleviate acute pancreatitis: pharmacological activities and mechanisms. Pancreas, 2021, 50(10): 1348-1356.
27.	中國醫師協會胰腺病專業委員會慢性胰腺炎專委會. 慢性胰腺炎診治指南(2018, 廣州). 中華消化內鏡雜志, 2018, 35(11): 814-822.
28.	中華醫學會急診分會, 京津冀急診急救聯盟, 北京醫學會急診分會, 等. 急性胰腺炎急診診斷及治療專家共識. 中華急診醫學雜志, 2021, 30(2): 161-172.
29.	Crockett SD, Wani S, Gardner TB, et al. Amercan Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018, 154(4): 1096-1101.
30.	L?hr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J, 2017, 5(2): 153-199.
31.	Weiss FU, Laemmerhirt F, Lerch MM. Etiology and risk factors of acute and chronic pancreatitis. Visc Med, 2019, 35(2): 73-81.
32.	Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis: the increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol, 2019, 13(6): 947-953.

1. 中華醫學會外科學分會胰腺外科學組. 中國急性胰腺炎診治指南(2021). 中華消化外科雜志, 2021, 20(7): 730-739.
2. Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology, 2016, 16(2): 218-224.
3. Sankaran SJ, Xiao AY, Wu LM, et al. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology, 2015, 149(6): 1490-1500.
4. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology, 2013, 144(6): 1252-1261.
5. Pokras S, Ray M, Zheng S, et al. The short- and long-term burden of acute pancreatitis in the United States: a retrospective cohort study. Pancreas, 2021, 50(3): 330-340.
6. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1204-1222.
7. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1223-1249.
8. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1789-1858.
9. 屈彥, 王天一, 楊津, 等. GBD數據庫的數據提取方法與流程. 中國循證心血管醫學雜志, 2019, 11(9): 1043-1046.
10. 孟令昊, 胥秋艷, 李科, 等. 1990~2019年中國女性宮頸癌疾病負擔變化的分析. 中國循證醫學雜志, 2021, 21(6): 648-653.
11. 王娜, 劉潔, 李曉東, 等. 中國1990~2019年結直腸癌疾病負擔分析. 中國循證醫學雜志, 2021, 21(5): 520-524.
12. Naghavi M, Makela S, Foreman K, et al. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr, 2010, 8: 9.
13. 宇傳華, 白建軍. 社會人口指數(SDI)的概念及其應用. 公共衛生與預防醫學, 2020, 31(1): 5-10.
14. 李輝章, 杜靈彬. Joinpoint回歸模型在腫瘤流行病學時間趨勢分析中的應用. 中華預防醫學雜志, 2020, 54(8): 908-912.
15. 曾四清. Joinpoint回歸模型及其在傳染病流行趨勢分析中的應用. 中國衛生統計, 2019, 36(5): 787-791.
16. Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet. 2020, 396(10252): 726-734.
17. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas, 2006, 33(4): 323-330.
18. Zheng Y, Zhou Z, Li H, et al. A multicenter study on etiology of acute pancreatitis in Beijing during 5 years. Pancreas, 2015, 44(3): 409-414.
19. 寧吉喆. 第七次全國人口普查主要數據情況. 中國統計, 2021, (5): 4-5.
20. Roberts SE, Akbari A, Thorne K, et al. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther, 2013, 38(5): 539-548.
21. Ouyang G, Pan G, Liu Q, et al. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. BMC Med, 2020, 18(1): 388.
22. 向斌, 張國培, 崔華永, 等. 大黃鼻飼對重癥胰腺炎腹腔感染的療效及對血管內皮糖萼的影響. 中國老年學雜志, 2021, 41(22): 4943-4946.
23. 馬玉景, 郎曉猛, 康欣, 等. 不同中藥注射液聯合常規治療用于重癥急性胰腺炎療效與安全性的網狀Meta分析. 中草藥, 2021, 52(24): 7583-7595.
24. 方婷, 莊一渝, 趙明明, 等. 重癥急性胰腺炎病人應用芒硝外敷護理效果的系統評價. 護理研究, 2018, 32(1): 49-54.
25. 黃野, 李紅昌, 孫文杰, 等. 大承氣湯治療重癥急性胰腺炎多中心隨機對照研究. 中國中西醫結合雜志, 2019, 39(8): 949-953.
26. Yang C, Wang T, Chen J, et al. Traditional Chinese medicine formulas alleviate acute pancreatitis: pharmacological activities and mechanisms. Pancreas, 2021, 50(10): 1348-1356.
27. 中國醫師協會胰腺病專業委員會慢性胰腺炎專委會. 慢性胰腺炎診治指南(2018, 廣州). 中華消化內鏡雜志, 2018, 35(11): 814-822.
28. 中華醫學會急診分會, 京津冀急診急救聯盟, 北京醫學會急診分會, 等. 急性胰腺炎急診診斷及治療專家共識. 中華急診醫學雜志, 2021, 30(2): 161-172.
29. Crockett SD, Wani S, Gardner TB, et al. Amercan Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018, 154(4): 1096-1101.
30. L?hr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J, 2017, 5(2): 153-199.
31. Weiss FU, Laemmerhirt F, Lerch MM. Etiology and risk factors of acute and chronic pancreatitis. Visc Med, 2019, 35(2): 73-81.
32. Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis: the increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol, 2019, 13(6): 947-953.

Next Article
Accuracy and influencing factors of diabetes-related subscriptions on the WeChat platform

Chinese Journal of Evidence-Based Medicine

Analysis of the disease burden of pancreatitis in China from 1990 to 2019

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content